The North America Facial Fat Transfer Market would witness market growth of 9.7% CAGR during the forecast period (2019-2025). The North America region accounted for the largest share in the global market for facial fat transfer, due to the growing demand for beauty treatments and the existence of significant players in the region. Non-invasive fat reduction and skin tightening have gained immense popularity among patients. For example, as per the American Society of Plastic Surgeons, injection-based treatments targeting fat pockets in specific areas, such as under the skin, increased by 18% in 2017. In addition, there is an accelerated demand for facial fat transfers in the Americas. Henceforth, the extensive success rate of facial fat grafting procedures is anticipated to fuel the market growth in the region.
Fat transfer provides a natural way to add volume to different areas of the body and enhance the contour. Plastic surgeons expect fat grafting to continue its upward trajectory in the years to come. It includes removing fat from one part of your body and shifting it to another area that needs to be improved. Fat transfer in NYC is used in both cosmetic and reconstructive processes. Fat transfer buttock augmentation is performed by highly-trained plastic surgeons. This makes it an ideal option for women who are looking for minor to moderate improvement in buttock size.
Based on Donor Site, the market is segmented into Flank, Thigh and Abdomen. Based on End Use, the market is segmented into Clinics & surgery centers and Hospitals. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Facial Fat Transfer Market in North America is expected to register a CAGR of 9.7% during the forecast period (2019-2025)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Allergan PLC, Integra LifeSciences Holdings Corporation, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, Ranfac Corporation, Cytori Therapeutics, Inc., Suneva Medical, Inc., Dr. Korman Laboratories Ltd., Scivision Biotech, Inc., and Teoxane Laboratories SA.
Market Segmentation:
By Donor Site
By End Use
By Country
Companies Profiled
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
